ASHEVILLE – Life sciences company Avadim Health, Inc. confidentially submitted a draft registration statement for a proposed initial public offering, the company said in a press release Monday.

The draft registration statement on Form S-1 was submitted to the Securities and Exchange Commission and both the number of offered shares and the price range remain undetermined.

The IPO is expected to take place following the SEC’s review process.

Avadim Health was founded in 2007 and offers solutions for the immune system, neuromuscular health and more. Theraworx Relief and Theraworx Protect are two of the company’s medicinal products for improvement in muscle cramps and skin protection, respectively.

This story is from the North Carolina Business News Wire, a service of UNC-Chapel Hill’s Hussman School of Journalism and Media.